Skip to content
10-K

Annual Report

RETINALGENIX TECHNOLOGIES INC. RTGN

0001641172-25-001788

← back to feed
Filed
Mar 31, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 31, 2025 18.52M sh
Shares Diluted FY 2024 · Dec 31, 2023 17.35M sh
Operating Cash Flow restated FY 2024 · Dec 31, 2023 −$451.66K
Current Liabilities FY 2024 · Dec 31, 2023 $1.41M
Total Liabilities FY 2024 · Dec 31, 2023 $1.41M
Total Assets FY 2024 · Dec 31, 2023 $156
Eps Diluted FY 2024 · Dec 31, 2023 −$0.12
Eps Basic FY 2024 · Dec 31, 2023 −$0.12
Sga Expense FY 2024 · Dec 31, 2023 $898.66K
Rd Expense FY 2024 · Dec 31, 2023 $524.18K
Net Income FY 2024 · Dec 31, 2023 −$2.09M